SmallCapReview.com is a leading small cap stock information site since 1999, to register for the free SmallCapReview newsletter visit http://www.smallcapreview.com/.
Osteologix (OTCBB: OLGX) $0.40. Today announced that is has received a Notice of Allowance from the U.S. Patent and Trademark Office for its U.S. Patent Application Number 11/269,289 titled "Water-Soluble Strontium Salts for Use in Treatment of Cartilage and/or Bone Conditions" reporting allowance of claims covering the treatment of osteoporosis and related bone conditions using NB S101 (strontium malonate), the Company's lead osteoporosis drug candidate. The Company expects the patent will issue in the second half of 2009; the patent's 20-year term would expire in 2024. The company has a number of other pending patent applications covering various aspects of the NB S101 drug program including composition, manufacturing and method of use patent applications.
What They Do: Osteologix is a specialty biopharmaceutical company committed to improving the health of those afflicted with musculoskeletal diseases, such as osteoporosis. Its lead investigational product candidate, NB S101, is a novel pharmaceutical agent for the treatment and prevention of osteoporosis.
Nuvilex, Inc. (OTCBB: NVLX) $0.035. Today announced that Infinitink(TM), the world's first permanent tattoo ink designed to be both safe and more easily removed, is the subject of a June 1st article in Time Magazine. The story, "Too Fickle for a Tattoo?" updates readers on Infinitink, a product developed to address tattoo regret and broaden the audience for this already popular art form.
What They Do: Nuvilex, formerly eFoodSafety.com, is an emerging healthcare consumer products company with a portfolio of aesthetics, dermatology, environmental and nutraceutical products. The company's focus is on developing, licensing and commercializing healthcare products that address the health needs of consumers worldwide.
Power Medical Interventions (Pinksheets: PMII) $0.53. Today announced that the U.S. Food and Drug Administration (FDA) has cleared its 510(k) application for marketing its iDrive Intelligent Power Unit(tm), detachable Intelligent Surgical Instruments and iConsole(tm). Based on the marketing clearance by the FDA, Power Medical Interventions (PMI) intends to launch the iDrive, Intelligent Surgical Instruments and iConsole products for commercial sale, effective immediately.
What They Do: Power Medical Interventions is the world's only provider of computer-assisted, power-actuated surgical cutting and stapling products. PMI's state-of-the-art wireless Intelligent Surgical Instruments(tm) are revolutionizing and expanding minimally invasive surgery applications and enabling novel surgical procedures to benefit surgeons, patients, hospitals and healthcare networks.
MoneyLogix Group (OTCBB: MLXG) $1.50. Today announced that it has acquired a development property totalling approximately 100 acres in Barrie, Ontario adjacent to the GO Train Station which provides daily commuter transit service to downtown Toronto. MoneyLogix is acquiring the property for the assumption of approximately C$9 million in debt and 8.775 million restricted common shares at C$2.00 per share for a total purchase price of C$26.3 million.
What They Do: MoneyLogix Group Inc., based in Ontario, Canada, is an early stage capital investment company focussed on opportunistic acquisitions in the real estate market.
About SmallCapReview
Copyright SmallCapReview. SmallCapReview.com has been a leading site for news on small-cap stocks since 1999. SmallCapReview has built a loyal opt-in following for their investor products by providing a newsletter at no cost, sent to subscribers, highlighting select small-cap stocks, to register visit http://www.smallcapreview.com/.
